Rare diseases
Investigational molecules
Locations
Study on the Effects of Vibozilimod for Adults with Moderate to Severe Atopic Dermatitis
PolandStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
PolandGedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy
PolandA study to evaluate the effectiveness and safety of BFB759 in adults with moderate to severe hidradenitis suppurativa
PolandA study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis
PolandA Study to Evaluate the Safety and Effectiveness of Ritlecitinib Tosilate in Adults with Moderate to Severe Hidradenitis Suppurativa
PolandA Study of Mevrometostat and Enzalutamide for Men with Metastatic Castration-Sensitive Prostate Cancer Who Have Not Received Hormonal Therapy or Chemotherapy
PolandA study testing NNC0194-0499, cagrilintide, and semaglutide alone or combined to treat liver damage in people with alcohol-related liver disease
PolandStudy of romiplostim for treating low platelet counts caused by chemotherapy in adults with non-small cell lung cancer, ovarian cancer, or breast cancer
PolandPolandA study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe
PolandA Study Testing Zasocitinib Compared to Placebo in Adults with Nonsegmental Vitiligo to See How Well It Works and How Safe It Is
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
